Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Add Yahoo as a preferred source to see more of our stories on Google. If you rely on the lifesaving drug epinephrine for severe allergic reactions, the controversy over high-priced auto-injectors ...
Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice ...
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...
Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...
In May, the Food and Drug Administration posted a drug shortage alert, adding Mylan's EpiPen (epinephrine injection) to the drug shortage list. A number of epinephrine auto-injector manufacturers have ...
Kaleo says it will reintroduce its an epinephrine autoinjector in the first half of 2017 The company says it has corrected manufacturing issues that led to a recall last year Pharmaceutical company ...
When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. If you rely on the lifesaving ...
Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results